ATE471713T1 - Tablette enthaltend fluvastatin und calciumcarmellose - Google Patents

Tablette enthaltend fluvastatin und calciumcarmellose

Info

Publication number
ATE471713T1
ATE471713T1 AT04740278T AT04740278T ATE471713T1 AT E471713 T1 ATE471713 T1 AT E471713T1 AT 04740278 T AT04740278 T AT 04740278T AT 04740278 T AT04740278 T AT 04740278T AT E471713 T1 ATE471713 T1 AT E471713T1
Authority
AT
Austria
Prior art keywords
tablet containing
fluvastatin
calcium carmellose
containing fluvastatin
carmellose
Prior art date
Application number
AT04740278T
Other languages
English (en)
Inventor
Tomoyuki Uehara
Kenji Taguchi
Kenichi Kitaoka
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE471713T1 publication Critical patent/ATE471713T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT04740278T 2003-06-25 2004-06-24 Tablette enthaltend fluvastatin und calciumcarmellose ATE471713T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25
PCT/EP2004/006865 WO2005000276A1 (en) 2003-06-25 2004-06-24 Tablet comprising fluvastatin and carmellose calcium

Publications (1)

Publication Number Publication Date
ATE471713T1 true ATE471713T1 (de) 2010-07-15

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04740278T ATE471713T1 (de) 2003-06-25 2004-06-24 Tablette enthaltend fluvastatin und calciumcarmellose

Country Status (21)

Country Link
US (1) US20090117181A1 (de)
EP (1) EP1641440B1 (de)
KR (1) KR20060030480A (de)
CN (1) CN1809342A (de)
AT (1) ATE471713T1 (de)
AU (1) AU2004251439B2 (de)
BR (1) BRPI0411855A (de)
CA (1) CA2529447A1 (de)
CO (1) CO5650224A2 (de)
DE (1) DE602004027808D1 (de)
EC (1) ECSP056238A (de)
IL (1) IL172531A0 (de)
IS (1) IS8249A (de)
MA (1) MA27889A1 (de)
MX (1) MXPA05013943A (de)
NO (1) NO20060261L (de)
NZ (1) NZ544119A (de)
RU (1) RU2361582C2 (de)
TN (1) TNSN05330A1 (de)
WO (1) WO2005000276A1 (de)
ZA (1) ZA200509930B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009527577A (ja) * 2006-02-24 2009-07-30 テバ ファーマシューティカル インダストリーズ リミティド フルバスタチンナトリウム医薬組成物
AU2011315555B2 (en) * 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
WO2012141160A1 (ja) 2011-04-12 2012-10-18 沢井製薬株式会社 ピタバスタチン含有製剤及びその製造方法
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
CA2399463A1 (en) * 2000-02-10 2001-08-16 Takeda Chemical Industries, Ltd. Combination drug
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
AU2001294192A1 (en) * 2000-10-06 2002-04-22 Takeda Chemical Industries Ltd. Solid preparations

Also Published As

Publication number Publication date
IL172531A0 (en) 2006-04-10
CA2529447A1 (en) 2005-01-06
CN1809342A (zh) 2006-07-26
TNSN05330A1 (en) 2007-07-10
NZ544119A (en) 2008-04-30
EP1641440A1 (de) 2006-04-05
ECSP056238A (es) 2006-04-19
ZA200509930B (en) 2007-01-31
EP1641440B1 (de) 2010-06-23
NO20060261L (no) 2006-01-18
WO2005000276A1 (en) 2005-01-06
MA27889A1 (fr) 2006-05-02
IS8249A (is) 2006-01-20
BRPI0411855A (pt) 2006-08-29
US20090117181A1 (en) 2009-05-07
AU2004251439A1 (en) 2005-01-06
RU2361582C2 (ru) 2009-07-20
KR20060030480A (ko) 2006-04-10
MXPA05013943A (es) 2006-02-24
DE602004027808D1 (de) 2010-08-05
AU2004251439B2 (en) 2008-09-11
CO5650224A2 (es) 2006-06-30
RU2006101889A (ru) 2007-08-10

Similar Documents

Publication Publication Date Title
NO20052309D0 (no) Nutrasoytisk mangostanblanding.
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NL1021822A1 (nl) Tamsulosinetabletten.
MA27889A1 (fr) Comprime contenant de la fluvastatine et de la carmellose calcique
NO20041195L (no) Tablettmater.
ZA200604874B (en) Pharmaceutical compositions
MXPA03009535A (es) Comprimido de meloxicam de rapida desintegracion.
ZA200408787B (en) Pharmaceutical combination.
ITFI20020246A1 (it) Contenitore sterile.
NL1025055A1 (nl) Verbeterd lampontwerp.
ES1052333Y (es) Cajon premarco.
NL1024812A1 (nl) Lampenkap.
ES1051309Y (es) Desmenuzador de especias.
ES1053557Y (es) Luminaria vertical empotrable.
SE0202435D0 (sv) Lykta, särskilt gravlykta
ES1053421Y (es) Linterna.
ES1055913Y (es) Linterna.
ES1053053Y (es) Destoconador vertical.
ES1052719Y (es) Lampara dinamica.
ITSS20020004A1 (it) Paella algherese.
ES1052131Y (es) Luminaria estanca mejorada.
GB0227756D0 (en) P.H. tablet
FI5009U1 (fi) Tabletti
ES1051308Y (es) Juego de sobremesa.
ITPN20020071A1 (it) Procedimento per la fabbricazione di mobili.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties